At GBS, we're focused on one and only one mission: to help talented entrepreneurs build great life science technology companies.

Otsuka Pharmaceutical Announces Positive Topline Results from Two Pivotal Phase 3 Trials of Centanafadine as a Treatment for Adolescents and Children with Attention-Deficit/Hyperactivity Disorder (ADHD)

27 / 10 / 2023

> Read More

FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis

10 / 04 / 2023

> Read More

Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study

22 / 09 / 2022

> Read More